Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy

NCT ID: NCT04125953

Last Updated: 2019-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-04

Study Completion Date

2020-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this research is to study the influence of stochastic modulated vibrations on the autonomic nervous system of breast cancer patients during radiation therapy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since it is well known that breast cancer patients experience an important load of stress from diagnosis through treatment and throughout cancer survivorship (fear of cancer recurrence), this study focusses on activation the parasympathetic nervous system and making patients as comfortable as possible during treatment. The scope of this study is based on previous research, that has shown that controlling physical and psychological complications during treatment may have a positive (preventive) effect on late term and long-term quality of life and survival outcomes. Breast cancer patients will receive andullation during their irradiation period. The primary outcome measure of the autonomic nervous system is vagal nerve activity, a modulator of the parasympathetic nervous system. Secondary outcome measures are stress, pain and lymphedema.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autonomic Nervous System Imbalance Psychological Distress Cancer-related Pain Breast Cancer Lymphedema Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized clinical trial
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

A 3 week intervention with Andullation will be performed, 3 times a week for 20 minutes after completion of the radiotherapy session

Group Type EXPERIMENTAL

Andullation

Intervention Type DEVICE

Andullation is a horizontal vibration technique with stochastically modulated vibrations, build-in in a mattress.

Control

This group will follow the same intervention protocol, but without the application of the Andullation technology

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Placebo Andullation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Andullation

Andullation is a horizontal vibration technique with stochastically modulated vibrations, build-in in a mattress.

Intervention Type DEVICE

Placebo

Placebo Andullation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histological proven breast cancer, following breast cancer surgery
* Starting with adjuvant radiation therapy for 3 weeks
* Minimum 18 years
* Medical record available and complete
* Supine lying on mattress for 20 minutes is possible
* Dutch, French or English

Exclusion Criteria

* Severe neurological, orthopaedic or rheumatic disorders
* Cardiac disorders
* Early or synchronous malignancy
* Pregnancy or lactation
* Persons suffering from depression or illnesses which influence the mental health or wellbeing
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitair Ziekenhuis Brussel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nele

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nele Adriaenssens, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Universitair Ziekenhuis Brussel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitair Ziekenhuis Brussel

Jette, Brussels Capital, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nele Adriaenssens, Prof. Dr.

Role: CONTACT

00324763623

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nele Adriaenssens, prof. dr.

Role: primary

024763623 ext. 0032

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018/455

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.